SHARK ANTIBODIES FOR CANCER THERAPY
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Aug 31, 2017
app pub date -
May 16, 2017
filing date -
May 16, 2017
priority date (Note) -
Published
status (Latency Note)
Importance
Abstract
Sharks have been thriving for over 500 million years. Sharks evolved some of the first adaptive antibodies and developed immunoglobulin M (IgM) as their primary and only class of circulating antibody. Laboratory research exposing sharks to carcinogens has failed to illicit cancers in these animals, and while reports of sharks bearing tumors exist, it is rare to find in nature.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully